Announced
Completed
Sofinnova, OMX and Vækstfonden led a $19.5m Series A round in Freya Biosciences.
Synopsis
Sofinnova, a venture capital firm, OMX, a venture capital firm, and Vækstfonden, Denmark's investment fund, led a $19.5m Series A round in Freya Biosciences, a clinical-stage company taking an innovative approach to women's health.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.